Skip to content
Declared

CRO company · CRO company 638245

CELLTRION HEALTHCARE IRELAND LIMITED

Company number
638245
Status
Normal
Type
LTD - Private Company Limited by Shares
Registered
2018-11-23
Registered office
SUITE 26 ARROW BUILDING, OLD BELGARD ROAD TALLAGHT, DUBLIN 24 D24 ND70 IRELAND, TALLAGHT,DUBLIN
Industry (NACE)
46.46 Wholesale of pharmaceutical goods
Latest accounts made up to
2024-12-31
Last annual return
2025-09-30
Next annual return date
2027-09-30
10
Awards
10 awards with a single named supplier
€15,088,696
Sole-supplier value
0
Shared awards
0
Declared by politicians

Directors, secretaries and shareholders are not in CRO's open data. CRO sells officer information through CORE; it is not shown here rather than guessed.

Timeline

Dated events from every connected source. Declarations are dated to the end of their registration period.

Download CSV 10 rows, with the filters applied

2026

  1. Contract awardsAward: Dynamic Purchasing System (DPS) Invitation for the provision of Authorised Medicinal ProductsHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €900,000
    TED
  2. Contract awardsAward: Dynamic Purchasing System (DPS) Invitation for the provision of Authorised Medicinal ProductsHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €900,000
    TED
  3. Contract awardsAward: Dynamic Purchasing System (DPS) Invitation for the provision of Authorised Medicinal ProductsHealth Service Executive → Celltrion Healthcare Ireland Limited. · €250,000
    TED
  4. Contract awardsAward: DPS Tender for the Supply of Rituximab Solution for Infusion to the Mater Misericordiae University HospitalHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €800,000
    TED

2025

  1. Contract awardsAward: DPS Tender for the Supply of Rituximab Solution for Infusion – CHI Hospital GroupHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €118,597
    TED
  2. Contract awardsAward: DPS Tender for the Supply of Infliximab Intravenous Infusion HSE West and North WestHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €8,435,709
    TED
  3. Contract awardsAward: HSE 25092 Supply of Infliximab Intravenous Infusion to Connolly Hospital Blanchardstown and Our Ladys Hospital NavanHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €597,790
    TED
  4. Contract awardsAward: Supply of Infliximab Intravenous Infusion to Children’s Health Ireland Hospital GroupHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €2,980,000
    TED

2024

  1. Contract awardsAward: MINI COMPETITION FOR THE SUPPLY OF RITUXIMAB SOLUTION FOR INFUSIONHealth Service Executive (HSE) → Celltrion Healthcare Ireland Limited. · €106,600
    OGP

2023

  1. Contract awardsAward: THE SUPPLY OF RITUXIMAB FOR INFUSIONSt. Vincent's University Hospital → Celltrion Healthcare Ireland Limited. · Not stated
    OGP